Mesenchymal stromal cell-based therapy in kidney diseases and transplantation
Intense investigation in pre-clinical models of kidney disease and transplantation showed that mesenchymal stromal cell (MSC) therapy acts on renal and inflammatory cells in multiple, complex and integrated ways, resulting in cell repair and regeneration, in the inhibition of inflammatory cells, an...
Main Authors: | Federica Casiraghi, Giuseppe Remuzzi |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2019-03-01
|
Series: | Italian Journal of Medicine |
Subjects: | |
Online Access: | https://italjmed.org/index.php/ijm/article/view/1072 |
Similar Items
-
Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation
by: Manuel Alfredo Podestà, et al.
Published: (2021-02-01) -
Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration
by: Federica Casiraghi, et al.
Published: (2020-04-01) -
Induction therapy with mesenchymal stromal cells in kidney transplantation: a meta-analysis
by: Lingfei Zhao, et al.
Published: (2021-03-01) -
Reparative and Regenerative Effects of Mesenchymal Stromal Cells—Promising Potential for Kidney Transplantation?
by: Merel Pool, et al.
Published: (2019-09-01) -
Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models
by: Adriana Torres Crigna, et al.
Published: (2018-06-01)